Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Dorr

Showing results (101-110 of 156) with videos related to

Pageof 16
Sort By:
Journal of Medicinal Chemistry|January 1, 1990
Alkylation of DNA by C-10 of 2,7-diaminomitoseneB S Iyengar, R T Dorr, N G Shipp, et al.
Anti-Cancer Drug Design|November 10, 1998
Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediolsR T Dorr, W Bellamy, J D Liddil, et al.
Toxicology|January 29, 1993
Administration of melanotropic peptides during gestation in the rodentB V Dawson, C A Ford, H Holloway, et al.
Cancer Treatment Reports|March 1, 1987
Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotesR T Dorr, D S Alberts, J Einspahr, et al.
Cancer Research|February 1, 1993
Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cellsN G Shipp, R T Dorr, D S Alberts, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumorsC W Taylor, R T Dorr, P Fanta, et al.
Cancer Treatment Reports|February 1, 1979
Limitations of a portable infusion pump in ambulatory patients receiving continuous infusions of anticancer drugsR T Dorr, C E Trinca, K Griffith, et al.
Annals of the New York Academy of Sciences|May 31, 1993
Melanotropic peptides for therapeutic and cosmetic tanning of the skinM E Hadley, S D Sharma, V J Hruby, et al.
Pharmaceutical Research|July 11, 2000
Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-IR Bhardwaj, M E Hadley, R T Dorr, et al.
Breast Cancer Research and Treatment|January 1, 1997
Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancerC W Taylor, W S Dalton, K Mosley, et al.
Pageof 16

Showing results (101-110 of 156) with videos related to

Sort By:
Pageof 16
Journal of Medicinal Chemistry|January 1, 1990
Alkylation of DNA by C-10 of 2,7-diaminomitoseneB S Iyengar, R T Dorr, N G Shipp, et al.
Anti-Cancer Drug Design|November 10, 1998
Correlation of cytotoxicity and protein-associated DNA strand breaks for 2-(arylmethylamino)-1,3-propanediolsR T Dorr, W Bellamy, J D Liddil, et al.
Toxicology|January 29, 1993
Administration of melanotropic peptides during gestation in the rodentB V Dawson, C A Ford, H Holloway, et al.
Cancer Treatment Reports|March 1, 1987
Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotesR T Dorr, D S Alberts, J Einspahr, et al.
Cancer Research|February 1, 1993
Characterization of experimental mitoxantrone cardiotoxicity and its partial inhibition by ICRF-187 in cultured neonatal rat heart cellsN G Shipp, R T Dorr, D S Alberts, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2001
A phase I and pharmacodynamic evaluation of polyethylene glycol-conjugated L-asparaginase in patients with advanced solid tumorsC W Taylor, R T Dorr, P Fanta, et al.
Cancer Treatment Reports|February 1, 1979
Limitations of a portable infusion pump in ambulatory patients receiving continuous infusions of anticancer drugsR T Dorr, C E Trinca, K Griffith, et al.
Annals of the New York Academy of Sciences|May 31, 1993
Melanotropic peptides for therapeutic and cosmetic tanning of the skinM E Hadley, S D Sharma, V J Hruby, et al.
Pharmaceutical Research|July 11, 2000
Pharmacologic response of a controlled-release PLGA formulation for the alpha-melanocyte stimulating hormone analog, Melanotan-IR Bhardwaj, M E Hadley, R T Dorr, et al.
Breast Cancer Research and Treatment|January 1, 1997
Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancerC W Taylor, W S Dalton, K Mosley, et al.
Pageof 16